Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
Zhenwei PengWenzhe FanBowen ZhuGuoying WangJun-Hui SunChengjiang XiaoFuxi HuangRong TangYu ChengZhen HuangYuchuang LiangHuishuang FanLiangliang QiaoFuliang LiWenquan ZhuangBaogang PengJiping WangJiaping LiMing KuangPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
The addition of TACE to LEN improves clinical outcomes and is a potential first-line treatment for patients with advanced HCC.